“…The justification for doing this is based on evidence which suggests that the development of polycythaemia can produce a poor prognosis in this condition (Mitchell, Webb, and Filley, 1964) due to the development of pulmonary hypertension and high blood viscosity producing heart failure and further hypoxia (Harvey et al, 1951;Renzetti, McClement, and Litt, 1966;Segel and Bishop, 1966;Dintenfass and Read, 1968;Agarwal, Paltoo, and Palmer, 1970). Furthermore, encouraging results have been obtained by those who have reduced the level of polycythaemia by, for example, using continuous oxygen (Chamberlain and Millard, 1963), venesection (Massaro and Katz, 1965;Rakita, Gillespie, and Sancetta, 1965), haemolytic drugs combined with marrow suppressants (Pengelly, 1966 and1969), and, more recently, exchange transfusion with Dextran 40 (Harrison, Gregory, Clark, and Scott, 1971). However, the efficacies of these measures need further assessment, as all these observations were made on relatively few patients without matched controls.…”